Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in Type 2 diabetes

Diabetic Medicine

Volumn 21, Issue 3, 2004, Pages 252-255

  Costa, L A ^a   Canani, L H ^a,b   Lisboa H R K ^c   Tres, G S ^c   Gross, J L ^a,d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b UNIVERSIDADE LUTERANA DO BRASIL   (Brazil)

^c UNIVERSITY OF PASSO FUNDO   (Brazil)

^d HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Chronic complications; Metabolic syndrome; Type 2 diabetes

Indexed keywords

ADULT; AGED; ARTICLE; BRAZIL; CLINICAL FEATURE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DYSLIPIDEMIA; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; METABOLIC SYNDROME X; MICROALBUMINURIA; NEUROPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; RETINOPATHY; STROKE;

ALBUMINURIA; CHOLESTEROL; CHRONIC DISEASE; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; PERIPHERAL NERVOUS SYSTEM DISEASES; PERIPHERAL VASCULAR DISEASES;

EID: 1542344887     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2004.01124.x     Document Type: Article

References (19)

1. Rainor J. Diabetes 2001 Vital Statistics. Alexandria: American Diabetes Association, 2001: 43-74.
2. UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-853.
3. Turner RC, Millns H, Neil HA, Stratton IM, Manley SE, Matthews DR et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom prospective diabetes study (UKPDS 23). Br Med J 1998; 316: 823-828.
4. World Health Organization. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Part 1, Diagnosis and Classification of Diabetes Mellitus. Geneva: WHO, 1999.
5. Isomaa B, Almgren P, Tuomi T, Forsen B, Lahti K, Nissen M et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 2001; 24: 683-689.
6. Isomaa B, Henricsson M, Almgren P, Tuomi T, Taskinen MR, Groop L. The metabolic syndrome influences the risk of chronic complications in patients with type II diabetes. Diabetologia 2001; 44: 1148-1154.
7. Canani LH, Gerchman F, Gross JL. Increased familial history of arterial hypertension, coronary heart disease, and renal disease in Brazilian type 2 diabetic patients with diabetic nephropathy. Diabetes Care 1998; 21: 1545-1550.
8. Rose G, Blackburn H, Gillum R, Prineas R. Cardiovascular Survey Methods. WHO Monograph Series, 2nd edn. Washington DC: WHO, 1982: 123-129.
9. Beck MO, Silveiro SP, Friedman R, Clausell N, Gross JL. Asymptomatic coronary artery disease is associated with cardiac autonomic neuropathy and diabetic nephropathy in type 2 diabetic patients. Diabetes Care 1999; 22: 1745-1747.
10. Lee YJ, Tsai JC. ACE gene insertion/deletion polymorphism associated with 1998 World Health Organization definition of metabolic syndrome in Chinese type 2 diabetic patients. Diabetes Care 2002; 25: 1002-1008.
11. Vanhala MJ, Kumpusalo EA, Pitkajarvi TK, Takala JK. Metabolic syndrome in a middle-aged Finnish population. J Cardiovasc Risk 1997; 4: 291-295.
12. Liese AD, Mayer-Davis EJ, Tyroler HA, Davis CE, Keil U, Schmidt MI et al. Familial components of the multiple metabolic syndrome: the ARIC Study. Diabetologia 1997; 40: 963-970.
13. Bonora E, Kiechl S, Willeit J, Oberhollenzer F, Egger G, Targher G et al. Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. Diabetes 1998; 47: 1643-1649.
14. Stamler J, Vaccaro O, Neaton JD, Wentworth D. Diabetes, other risk factors, and 12-yr cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 1993; 16: 434-444.
15. Nielsen S, Schmitz O, Orskov H, Mogensen CE. Similar insulin sensitivity in NIDDM patients with normo-and microalbuminuria. Diabetes Care 1995; 18: 834-842.
16. Hodge AM, Dowse GK, Zimmet PZ. Microalbuminuria, cardiovascular risk factors, and insulin resistance in two populations with a high risk of type 2 diabetes mellitus. Diabet Med 1996; 13: 441-449.
17. Jager A, Kostense PJ, Nijpels G, Heine RJ, Bouter LM, Stehouwer CD. Microalbuminuria is strongly associated with NIDDM and hypertension, but not with the insulin resistance syndrome: the Hoorn Study. Diabetologia 1998; 41: 694-700.
18. Groop L, Ekstrand A, Forsblom C, Widen E, Groop PH, Teppo AM et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 1993; 36: 642-647.
19. Lee RH, Dellon AL. Insulin resistance. Does it play a role in peripheral neuropathy? Diabetes Care 1999; 22: 1914-1915.